• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Spain Pharmaceuticals and Healthcare Report Q1 2013 - Product Image

Spain Pharmaceuticals and Healthcare Report Q1 2013

  • Published: February 2013
  • Region: Spain
  • 93 pages
  • Business Monitor International

BMI View

The move towards increased out-of-pocket drug expenditure (via the de-reimbursement of medicines and increased medicine co-payments) will put more pressure on the finances of the Spanish population. Double-digit unemployment, deflating asset prices (particularly real estate) and rising inflation
(which is eating into real wages) have already significantly weakened final demand and in addition to the drug price erosion mechanisms employed by the government, will significantly restrict drug companies'
revenue-earning opportunities.

Headline Expenditure Projections
- Pharmaceuticals: EUR20.15bn (US$28.01bn) in 2011 to EUR18.34bn (US$23.30bn) in 2012; -9.0% in local currency terms and -16.8% in US dollar terms.

- Healthcare: EUR104.99bn (US$145.93bn) in 2011 to EUR105.43bn (US$133.91bn) in 2012; +0.4% in local currency terms and -8.2% in US dollar terms.

- Medical Devices: EUR4.32bn (US$6.01bn) in 2011 to EUR4.35bn (US$5.52bn) in 2011; +0.7% in local currency terms and -8.0% in US dollar terms.

BMI Industry View 7

Executive Summary 7

SWOT 9

Spain Pharmaceuticals And Healthcare Industry SWOT 9

Political 11

Economic 12

Business Environment 13

Industry Forecast 14

Overall Market Forecast 14
Table: Spain Pharmaceutical Sales Indicators 2008-2016 15

Key Growth Factors - Industry 16
Table: Spain Healthcare Indicators 2008-2016 17

Economic Analysis 17
Table: Spain - Economic Activity 22

Presription Drug Market Forecast 23
Table: Spain Prescription Drug Sales Indicators 2008-2016 24

Patented Drug Market Forecast 25
Table: Patented Drug Market Indicators 2008-2016 26

Generic Drug Market Forecast 26
Table: Generic Drug Sales Indicators 2008-2016 27

OTC Medicines Market Forecast 28
Table: Spain OTC Medicine Sales Indicators 2008-2016 29

Pharmaceutical Trade Forecast 29
Table: Table: Exports and Imports Indicators 2008-2016 30

Medical Device Market Forecast 31
Table: Medical Devices Sales Indicators 2008-2016 33

Other Healthcare Data 33

Key Risks 33

Industry Risk Reward Ratings 35

Pharmaceuticals Risk/Reward Ratings 35
Table: Western Europe Pharmaceuticals And Healthcare Risk/Reward Ratings, Q113 35

Market Overview 38

Industry Trends And Developments 40

Epidemiology 40

Healthcare Sector 41

Research & Development 43

Clinical Trials 45

Medical Devices 46

Regulatory Development 48

Intellectual Property Issues 49

Parallel Trade 50

OTC Medicines 51

Generic Medicines 52

Pricing Regime 52

Reference Pricing System 55

Reimbursement Regime 58

Competitive Landscape 60

Pharmaceutical Sector 60

Generic Drug Sector 60

Biotechnology Sector 62

Pharmaceutical Retail 64

Company Profile 67

Almirall 67

Esteve 71

GlaxoSmithKline 74

Pfizer 76

Novartis 79

Sanofi 81

Merck & Co 83

Demographic Forecast 85
Table: Spain's Population By Age Group, 1990-2020 ('000) 86
Table: Spain's Population By Age Group, 1990-2020 (% of total) 86
Table: Spain's Key Population Ratios, 1990-2020 87
Table: Spain's Rural And Urban Population, 1990-2020 88

Glossary 89

Methodology 91

Methodology 91

Risk/Reward Ratings Methodology 91

Ratings Overview 92
Table: Pharmaceutical Business Environment Indicators 92

Weighting 93
Table: Weighting Of Components 93

Sources 93

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos